[HTML][HTML] Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
AK Misra, NL Wong, TT Healey, EV Lally… - BMC Pulmonary …, 2021 - Springer
Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies.
AK Misra, NL Wong, TT Healey, EV Lally… - BMC Pulmonary …, 2021 - europepmc.org
Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
AK Misra, NL Wong, TT Healey… - BMC pulmonary …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
[HTML][HTML] Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
AK Misra, NL Wong, TT Healey, EV Lally… - BMC Pulmonary …, 2021 - ncbi.nlm.nih.gov
Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies.
AK Misra, NL Wong, TT Healey, EV Lally… - BMC Pulmonary …, 2021 - go.gale.com
Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
AK Misra, NL Wong, TT Healey… - BMC Pulmonary …, 2021 - search.proquest.com
Background Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
[HTML][HTML] Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
AK Misra, NL Wong, TT Healey… - BMC …, 2021 - bmcpulmmed.biomedcentral.com
Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating myositis-
specific antibodies (MSAs). Interstitial lung disease (ILD) is a common manifestation of …
specific antibodies (MSAs). Interstitial lung disease (ILD) is a common manifestation of …
[PDF][PDF] Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
AK Misra, NL Wong, TT Healey, EV Lally… - 2021 - bmcpulmmed.biomedcentral.com
Background: Many patients with polymyositis (PM) or dermatomyositis (DM) have circulating
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …
myositis-specific antibodies (MSAs). Interstitial lung disease (ILD) is a common …